Literature DB >> 33584056

Histopathological Examination of the Effects of Local and Systemic Bisphosphonate Usage in Bone Graft Applications on Bone Healing.

Sabit Demircan1, S Cemil İşler2.   

Abstract

BACKGROUND: The effect of bisphosphonates on the resorption process of normal bone tissue has been clearly mentioned in the literature, while their effect on the grafting material is a new research area. Limited former study is not sufficient to determine the strength, reliability and dosage of bisphosphonates. In this study, our aim is to examine the effects of local and systemic use of bisphosphonates in bone graft applications on bone healing, histopathologically.
METHODS: Therefore, 32 Sprague-Dawley rats are separated into four groups. In the first group, only an empty bone defect is made on tibia and the tissue is sutured primarily without any other application. In the second group, bone defect is filled with allograft material and closed without any other application. In the third group (LA), alendronate solution is locally added to the graft material before its application to the site of bone defect. In the fourth group, alendronate is applied systemically after the site of bone defect is grafted and primarily closed. After 6 weeks, all rats are killed and the obtained samples are examined histopathologically.
RESULTS: Local and systemic application of alendronate increases new bone formation in a statistically significant degree. In LA group, newly formed bone was observed more mature and well developed. Alendronate application does not cause an increase in inflammation, fibrosis and necrosis. There is no increased necrosis with alendronate application.
CONCLUSION: Local and systemic application of alendronate in bone grafting increases bone formation without any other complication. But we believe that further research should be made on dosage, usage and possible side effects. © The Association of Oral and Maxillofacial Surgeons of India 2020.

Entities:  

Keywords:  Alendronate; Bisphosphonates; Bone graft; Bone healing

Year:  2020        PMID: 33584056      PMCID: PMC7855145          DOI: 10.1007/s12663-020-01335-w

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  23 in total

Review 1.  Bone graft harvesting from distant sites: concepts and techniques.

Authors:  Kenneth J Zouhary
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2010-08       Impact factor: 2.802

2.  Local administration of alendronate reduced peri-tunnel bone loss and promoted graft-bone tunnel healing with minimal systemic effect on bone in contralateral knee.

Authors:  Pauline Po Yee Lui; Yuk Wa Lee; Tsui Yu Mok; Yau Chuk Cheuk
Journal:  J Orthop Res       Date:  2013-07-22       Impact factor: 3.494

Review 3.  Role of local alendronate delivery on the osseointegration of implants: a systematic review and meta-analysis.

Authors:  S V Kellesarian; T Abduljabbar; F Vohra; V R Malignaggi; H Malmstrom; G E Romanos; F Javed
Journal:  Int J Oral Maxillofac Surg       Date:  2017-03-31       Impact factor: 2.789

4.  A bisphosphonate-coating improves the fixation of metal implants in human bone. A randomized trial of dental implants.

Authors:  Jahan Abtahi; Pentti Tengvall; Per Aspenberg
Journal:  Bone       Date:  2012-02-10       Impact factor: 4.398

5.  Local delivery of an amino bisphosphonate prevents the resorptive phase of alveolar bone following mucoperiosteal flap surgery in rats.

Authors:  A Yaffe; M Iztkovich; Y Earon; I Alt; R Lilov; I Binderman
Journal:  J Periodontol       Date:  1997-09       Impact factor: 6.993

6.  Bone allografts pretreated with a bisphosphonate are not resorbed.

Authors:  Per Aspenberg; Jörgen Astrand
Journal:  Acta Orthop Scand       Date:  2002-01

7.  Inhibitory effect of alendronate on bone resorption of autogenous free bone grafts in rats.

Authors:  Hatice Altundal; Hakan Sayrak; Ertuğrul Yurtsever; Kamil Göker
Journal:  J Oral Maxillofac Surg       Date:  2007-03       Impact factor: 1.895

8.  Topical, single dose bisphosphonate treatment reduced bone resorption in a rat model for prosthetic loosening.

Authors:  Jörgen Astrand; Per Aspenberg
Journal:  J Orthop Res       Date:  2004-03       Impact factor: 3.494

9.  Alendronate modulates osteogenesis of human osteoblastic cells in vitro.

Authors:  M Tsuchimoto; Y Azuma; O Higuchi; I Sugimoto; N Hirata; M Kiyoki; I Yamamoto
Journal:  Jpn J Pharmacol       Date:  1994-09

10.  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; John Fantasia; Reginald Goodday; Tara Aghaloo; Bhoomi Mehrotra; Felice O'Ryan
Journal:  J Oral Maxillofac Surg       Date:  2014-05-05       Impact factor: 2.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.